| Dr Kevin Michael Lunney, MD, PHD | |
|
100 Brewster Blvd, Naval Hospital, Camp Lejeune, NC 28547-2538 | |
| (910) 450-4159 | |
| (910) 450-4194 |
| Full Name | Dr Kevin Michael Lunney |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 15 Years |
| Location | 100 Brewster Blvd, Camp Lejeune, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770886483 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | A114959 (California) | Primary |
| 207P00000X | Emergency Medicine | 01087852A (Indiana) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Johns Regional Medical Center | Oxnard, CA | Hospital |
| Emanuel Medical Center | Turlock, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cep America - California | 6103739131 | 954 |
News Archive
Altor, a leading Nordic buy-out fund, today announced that it has signed a definitive agreement to sell PaloDEx to Danaher Corporation. Altor acquired the dental imaging assets from GE as a carve-out of non-core assets in September 2005 and formed a leading dental imaging company named PaloDEx.
The Massachusetts Eye and Ear Infirmary (MEEI) has announced that the United States District Court for the District of Massachusetts, Judge William G. Young, following a Nov. 6, 2006 jury decision, ruled in favor of MEEI on claims of unjust enrichment and unfair trade practices against QLT Inc.
Inhibitex, Inc. today reported positive top-line safety and antiviral data from its multiple ascending dose Phase 1b clinical trial of INX-189, an oral nucleotide polymerase inhibitor being developed to treat chronic infections caused by hepatitis C virus.
CAS Medical Systems has announced that it has been awarded two United States Patents for technology used in its Fore-Sight Cerebral Oximeter, which is scheduled for commercial release in late 2006.
Researchers recently found that a single dose of a vaccine being developed by Medicago, Inc., a publicly traded biopharmaceutical company, could protect against not only the avian influenza (H5N1) strain it was designed for, but also another H5N1 strain and a strain of a different flu subtype, called H2N2.
› Verified 2 days ago
| Entity Name | Cep America - California |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023063542 PECOS PAC ID: 6103739131 Enrollment ID: O20031106000520 |
News Archive
Altor, a leading Nordic buy-out fund, today announced that it has signed a definitive agreement to sell PaloDEx to Danaher Corporation. Altor acquired the dental imaging assets from GE as a carve-out of non-core assets in September 2005 and formed a leading dental imaging company named PaloDEx.
The Massachusetts Eye and Ear Infirmary (MEEI) has announced that the United States District Court for the District of Massachusetts, Judge William G. Young, following a Nov. 6, 2006 jury decision, ruled in favor of MEEI on claims of unjust enrichment and unfair trade practices against QLT Inc.
Inhibitex, Inc. today reported positive top-line safety and antiviral data from its multiple ascending dose Phase 1b clinical trial of INX-189, an oral nucleotide polymerase inhibitor being developed to treat chronic infections caused by hepatitis C virus.
CAS Medical Systems has announced that it has been awarded two United States Patents for technology used in its Fore-Sight Cerebral Oximeter, which is scheduled for commercial release in late 2006.
Researchers recently found that a single dose of a vaccine being developed by Medicago, Inc., a publicly traded biopharmaceutical company, could protect against not only the avian influenza (H5N1) strain it was designed for, but also another H5N1 strain and a strain of a different flu subtype, called H2N2.
› Verified 2 days ago
| Entity Name | Cep America - California |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548667843 PECOS PAC ID: 6103739131 Enrollment ID: O20040121000458 |
News Archive
Altor, a leading Nordic buy-out fund, today announced that it has signed a definitive agreement to sell PaloDEx to Danaher Corporation. Altor acquired the dental imaging assets from GE as a carve-out of non-core assets in September 2005 and formed a leading dental imaging company named PaloDEx.
The Massachusetts Eye and Ear Infirmary (MEEI) has announced that the United States District Court for the District of Massachusetts, Judge William G. Young, following a Nov. 6, 2006 jury decision, ruled in favor of MEEI on claims of unjust enrichment and unfair trade practices against QLT Inc.
Inhibitex, Inc. today reported positive top-line safety and antiviral data from its multiple ascending dose Phase 1b clinical trial of INX-189, an oral nucleotide polymerase inhibitor being developed to treat chronic infections caused by hepatitis C virus.
CAS Medical Systems has announced that it has been awarded two United States Patents for technology used in its Fore-Sight Cerebral Oximeter, which is scheduled for commercial release in late 2006.
Researchers recently found that a single dose of a vaccine being developed by Medicago, Inc., a publicly traded biopharmaceutical company, could protect against not only the avian influenza (H5N1) strain it was designed for, but also another H5N1 strain and a strain of a different flu subtype, called H2N2.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kevin Michael Lunney, MD, PHD 100 Brewster Blvd, Naval Hospital, Camp Lejeune, NC 28547-2538 Ph: (910) 450-4159 | Dr Kevin Michael Lunney, MD, PHD 100 Brewster Blvd, Naval Hospital, Camp Lejeune, NC 28547-2538 Ph: (910) 450-4159 |
News Archive
Altor, a leading Nordic buy-out fund, today announced that it has signed a definitive agreement to sell PaloDEx to Danaher Corporation. Altor acquired the dental imaging assets from GE as a carve-out of non-core assets in September 2005 and formed a leading dental imaging company named PaloDEx.
The Massachusetts Eye and Ear Infirmary (MEEI) has announced that the United States District Court for the District of Massachusetts, Judge William G. Young, following a Nov. 6, 2006 jury decision, ruled in favor of MEEI on claims of unjust enrichment and unfair trade practices against QLT Inc.
Inhibitex, Inc. today reported positive top-line safety and antiviral data from its multiple ascending dose Phase 1b clinical trial of INX-189, an oral nucleotide polymerase inhibitor being developed to treat chronic infections caused by hepatitis C virus.
CAS Medical Systems has announced that it has been awarded two United States Patents for technology used in its Fore-Sight Cerebral Oximeter, which is scheduled for commercial release in late 2006.
Researchers recently found that a single dose of a vaccine being developed by Medicago, Inc., a publicly traded biopharmaceutical company, could protect against not only the avian influenza (H5N1) strain it was designed for, but also another H5N1 strain and a strain of a different flu subtype, called H2N2.
› Verified 2 days ago
Mr. Justin Thomas Daughtry, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 100 Brewster Blvd, Camp Lejeune, NC 28547 Phone: 910-450-4841 | |
Matthew Patrick Sullivan, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 100 Brewster Blvd, Naval Hospital, Camp Lejeune, NC 28547 Phone: 910-450-4159 Fax: 910-450-4194 | |
Liam Francis Delahanty, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 100 Brewster Blvd, Camp Lejeune, NC 28547 Phone: 518-860-4677 | |
Dr. Ellie Lee Burns, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 Brewster Blvd, Naval Hospital, Camp Lejeune, NC 28547 Phone: 910-450-4159 Fax: 910-450-4194 | |
Dr. Eric Bruce Draper, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 100 Brewster Blvd, Naval Hospital, Camp Lejeune, NC 28547 Phone: 910-450-4840 | |
Dr. Luis E Marquez, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 100 Brewster Blvd, Camp Lejeune, NC 28547 Phone: 910-450-4840 | |
Dr. James Austin Yoder, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: Naval Medical Center, 100 Brewster Blvd, Camp Lejeune, NC 28547 Phone: 910-450-4053 |